GFAP and early-onset autosomal dominant Alzheimer disease: Since E. cava has shown a protective effect against NI and apoptosis, and given that NI and ND are interrelated processes, we measured glial fibrillary acidic protein (GFAP), a biomarker used to diagnose Alzheimer’s disease [61].